1-13 of 13
Julie R. Brahmer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Divergent clinical and immunologic outcomes based on STK11 co-mutation status in resectable KRAS-mutant lung cancers following neoadjuvant immune checkpoint blockade

Samuel Rosner, Sydney Connor, Khaled Sanber, Marianna Zahurak, Tianbei Zhang, Isha Gurumurthy, Zhen Zeng, Brad Presson, Dipika Singh, Roni Rayes, Lavanya Sivapalan, Gavin Pereira, Zhicheng Ji, Rohit Thummalapalli, Joshua E. Reuss, Stephen R. Broderick, David R. Jones, Julie S. Deutsch, Tricia R. Cottrell, Jamie Chaft, Jonathan Spicer, Janis Taube, Valsamo Anagnostou, Julie R. Brahmer, Drew M. Pardoll, Hongkai Ji, Patrick M. Forde, Kristen A. Marrone, Kellie N. Smith
Journal: Clinical Cancer Research
Clin Cancer Res (2024)
https://doi.org/10.1158/1078-0432.CCR-24-2983
Published: 15 November 2024
View article titled, Divergent clinical and immunologic outcomes based on STK11 co-mutation status in resectable KRAS-mutant lung cancers following neoadjuvant immune checkpoint blockade
Open the PDF for Divergent clinical and immunologic outcomes based on STK11 co-mutation status in resectable KRAS-mutant lung cancers following neoadjuvant immune checkpoint blockade in another window
Includes: Supplementary data
Journal Articles

Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer

Joseph C. Murray, Lavanya Sivapalan, Karlijn Hummelink, Archana Balan, James R. White, Noushin Niknafs, Lamia Rhymee, Gavin Pereira, Nisha Rao, Benny Weksler, Nathan Bahary, Jillian Phallen, Alessandro Leal, David L. Bartlett, Kristen A. Marrone, Jarushka Naidoo, Akul Goel, Benjamin Levy, Samuel Rosner, Christine L. Hann, Susan C. Scott, Josephine Feliciano, Vincent K. Lam, David S. Ettinger, Qing Kay Li, Peter B. Illei, Kim Monkhorst, Robert B. Scharpf, Julie R. Brahmer, Victor E. Velculescu, Ali H. Zaidi, Patrick M. Forde, Valsamo Anagnostou
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (2): 389–403.
https://doi.org/10.1158/1078-0432.CCR-23-1469
Published: 17 January 2024
View article titled, Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer
Open the PDF for Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer

Samuel Rosner, Joshua E. Reuss, Marianna Zahurak, Jiajia Zhang, Zhen Zeng, Janis Taube, Valsamo Anagnostou, Kellie N. Smith, Joanne Riemer, Peter B. Illei, Stephen R. Broderick, David R. Jones, Suzanne L. Topalian, Drew M. Pardoll, Julie R. Brahmer, Jamie E. Chaft, Patrick M. Forde
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (4): 705–710.
https://doi.org/10.1158/1078-0432.CCR-22-2994
Published: 16 February 2023
View article titled, Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer
Open the PDF for Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non–Small Cell Lung Cancer

Jiajia Zhang, Zhicheng Ji, Justina X. Caushi, Margueritta El Asmar, Valsamo Anagnostou, Tricia R. Cottrell, Hok Yee Chan, Prerna Suri, Haidan Guo, Taha Merghoub, Jamie E. Chaft, Joshua E. Reuss, Ada J. Tam, Richard L. Blosser, Mohsen Abu-Akeel, John-William Sidhom, Ni Zhao, Jinny S. Ha, David R. Jones, Kristen A. Marrone, Jarushka Naidoo, Edward Gabrielson, Janis M. Taube, Victor E. Velculescu, Julie R. Brahmer, Franck Housseau, Matthew D. Hellmann, Patrick M. Forde, Drew M. Pardoll, Hongkai Ji, Kellie N. Smith
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (6): 1327–1337.
https://doi.org/10.1158/1078-0432.CCR-19-2931
Published: 13 March 2020
View article titled, Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non–Small Cell Lung Cancer
Open the PDF for Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Immune Checkpoint Modulation for Non–Small Cell Lung Cancer

Jean-Charles Soria, Aurélien Marabelle, Julie R. Brahmer, Scott Gettinger
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (10): 2256–2262.
https://doi.org/10.1158/1078-0432.CCR-14-2959
Published: 14 May 2015
View article titled, Immune Checkpoint Modulation for Non–Small Cell Lung Cancer
Open the PDF for Immune Checkpoint Modulation for Non–Small Cell Lung Cancer in another window
Journal Articles

Cancer Immunotherapy: A Future Paradigm Shift in the Treatment of Non–Small Cell Lung Cancer

Valsamo K. Anagnostou, Julie R. Brahmer
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (5): 976–984.
https://doi.org/10.1158/1078-0432.CCR-14-1187
Published: 01 March 2015
View article titled, Cancer Immunotherapy: A Future Paradigm Shift in the Treatment of Non–Small Cell Lung Cancer
Open the PDF for Cancer Immunotherapy: A Future Paradigm Shift in the Treatment of Non–Small Cell Lung Cancer in another window
Journal Articles

Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy

Janis M. Taube, Alison Klein, Julie R. Brahmer, Haiying Xu, Xiaoyu Pan, Jung H. Kim, Lieping Chen, Drew M. Pardoll, Suzanne L. Topalian, Robert A. Anders
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (19): 5064–5074.
https://doi.org/10.1158/1078-0432.CCR-13-3271
Published: 30 September 2014
View article titled, Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy
Open the PDF for Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy in another window
Includes: Supplementary data
Journal Articles

New Strategies in Lung Cancer: Epigenetic Therapy for Non–Small Cell Lung Cancer

Patrick M. Forde, Julie R. Brahmer, Ronan J. Kelly
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (9): 2244–2248.
https://doi.org/10.1158/1078-0432.CCR-13-2088
Published: 30 April 2014
View article titled, New Strategies in Lung Cancer: Epigenetic Therapy for Non–Small Cell Lung Cancer
Open the PDF for New Strategies in Lung Cancer: Epigenetic Therapy for Non–Small Cell Lung Cancer in another window
Journal Articles

New Strategies in Lung Cancer: Translating Immunotherapy into Clinical Practice

Patrick M. Forde, Ronan J. Kelly, Julie R. Brahmer
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (5): 1067–1073.
https://doi.org/10.1158/1078-0432.CCR-13-0731
Published: 02 March 2014
View article titled, New Strategies in Lung Cancer: Translating Immunotherapy into Clinical Practice
Open the PDF for New Strategies in Lung Cancer: Translating Immunotherapy into Clinical Practice in another window
Journal Articles

Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody

Evan J. Lipson, William H. Sharfman, Charles G. Drake, Ira Wollner, Janis M. Taube, Robert A. Anders, Haiying Xu, Sheng Yao, Alice Pons, Lieping Chen, Drew M. Pardoll, Julie R. Brahmer, Suzanne L. Topalian
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (2): 462–468.
https://doi.org/10.1158/1078-0432.CCR-12-2625
Published: 16 January 2013
View article titled, Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody
Open the PDF for Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody in another window
Journal Articles

Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors

Patricia M. LoRusso, Charles M. Rudin, Josina C. Reddy, Raoul Tibes, Glen J. Weiss, Mitesh J. Borad, Christine L. Hann, Julie R. Brahmer, Ilsung Chang, Walter C. Darbonne, Richard A. Graham, Kenn L. Zerivitz, Jennifer A. Low, Daniel D. Von Hoff
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2502–2511.
https://doi.org/10.1158/1078-0432.CCR-10-2745
Published: 14 April 2011
View article titled, Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors
Open the PDF for Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel

Sharyn D. Baker, Ming Zhao, Carlton K. K. Lee, Jaap Verweij, Yelena Zabelina, Julie R. Brahmer, Antonio C. Wolff, Alex Sparreboom, Michael A. Carducci
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (6): 1976–1983.
https://doi.org/10.1158/1078-0432.CCR-0842-03
Published: 24 March 2004
View article titled, Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel
Open the PDF for Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel in another window
Journal Articles

Phase I Study of Docosahexaenoic Acid-Paclitaxel: a Taxane-Fatty Acid Conjugate with a Unique Pharmacology and Toxicity Profile

Antonio C. Wolff, Ross C. Donehower, M. Katherine Carducci, Michael A. Carducci, Julie R. Brahmer, Yelena Zabelina, Matthews O. Bradley, Forrest H. Anthony, Charles S. Swindell, Philip A. Witman, Nigel L. Webb, Sharyn D. Baker
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3589–3597.
Published: 23 September 2003
View article titled, Phase I Study of Docosahexaenoic Acid-Paclitaxel: <subtitle>a Taxane-Fatty Acid Conjugate with a Unique Pharmacology and Toxicity Profile</subtitle>
Open the PDF for Phase I Study of Docosahexaenoic Acid-Paclitaxel: <subtitle>a Taxane-Fatty Acid Conjugate with a Unique Pharmacology and Toxicity Profile</subtitle> in another window